Status:

COMPLETED

Clinical Trial of Topiramate for Cocaine Addiction

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Cocaine Dependence

Eligibility:

All Genders

18-55 years

Phase:

PHASE2

Brief Summary

This is an outpatient clinical trial of topiramate for addressing cocaine dependence and reduction of cocaine associated behaviors in opiate dependent drug users maintained on methadone treatment. Th...

Detailed Description

This is an outpatient clinical trial of topiramate treatment for cocaine dependence and reduction of cocaine-associated HIV risk behavior. Topiramate is of high current interest in this regard, having...

Eligibility Criteria

Inclusion

  • 18 - 55 years old
  • active opioid and cocaine dependence
  • seeking treatment for cocaine and opioid dependence
  • eligible for methadone maintenance per state and federal regulations
  • able and willing to provide a urine sample thrice a week
  • willing to answer questionnaires on a weekly basis
  • willing to provide breath samples for presence of alcohol thrice weekly
  • fluent in the English language

Exclusion

  • allergy to sulfonamide drugs
  • diabetes, respiratory insufficiency, renal tubular acidosis, renal insufficiency, heart failure, liver insufficiency, chronic diarrhea, other chronic diseases predisposing to a risk of acidosis
  • history of nephrolithiasis
  • HIV positive individuals who meet AIDS criteria by CDC criteria or are taking antiretroviral medications
  • serious psychiatric illness (psychosis, dementia)
  • glaucoma or family history of glaucoma
  • prostate hyperplasia, shy bladder, irritable bladder, difficulty providing urine samples on demand
  • female participants: being pregnant, lactating, or unwilling to use an effective method of contraception
  • use of antiepileptic agents
  • benzodiazepine dependence
  • latex allergy

Key Trial Info

Start Date :

February 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2011

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT00685178

Start Date

February 1 2007

End Date

September 1 2011

Last Update

July 11 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Behavioral Pharmacology Research Unit

Baltimore, Maryland, United States, 21224